Related Experiment Video

Updated: Jul 4, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

[Leuconostoc sp in cancer patients: a descriptive study]

Sonia I Cuervo M1, Jorge Cortés L, Elizabeth Rodríguez R

  • 1Departamento de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. sicuervom@unal.edu.co

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|June 27, 2008
PubMed

Insights

Leuconostoc species are rare opportunistic pathogens often found in critically ill patients, particularly those with cancer. This study reviews their infections in cancer patients, highlighting clinical conditions and treatment approaches.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Oncology

Context:

  • Leuconostoc species are increasingly recognized as opportunistic pathogens.
  • These bacteria are frequently isolated in nosocomial infections, especially in critically ill patients and immunocompromised hosts.
  • Commonly associated with bacteremia linked to intravascular devices and total parenteral nutrition.

Purpose:

  • To describe the clinical characteristics and conditions of cancer patients experiencing Leuconostoc infections.
  • To conduct a comprehensive literature review on Leuconostoc sp. infections in oncology patients.
  • To enhance understanding of the spectrum of Leuconostoc infections in this vulnerable population.

Summary:

  • The study details a series of cancer patients diagnosed with Leuconostoc infections.
  • It outlines the associated clinical conditions and patient outcomes.
  • A review of existing literature on Leuconostoc infections in cancer patients is presented.

Impact:

  • Provides valuable insights into the clinical presentation and management of Leuconostoc infections in cancer patients.
  • Highlights the importance of considering Leuconostoc as a potential pathogen in oncology settings.
  • Contributes to the body of knowledge regarding rare opportunistic infections in immunocompromised individuals.

More Related Videos

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...